Showing results (701-710 of 1,096) with videos related to

Sort By:
Pageof 110
Bioorganic & Medicinal Chemistry Letters|June 9, 2014
Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groupsBrian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Molecular Cytogenetics|August 25, 2015
Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progressionJun Gu, Keyur P Patel, Bing Bai, et al.
Pathology|October 8, 2025
Clinicopathological features of primary epidural B-cell lymphoma: a study of 14 casesWei J Wang, Zhihong Hu, Brandon T Gehris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2026
Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption and Dismal PrognosisQing Wei, L Jeffrey Medeiros, Sanam Loghavi, et al.
Leukemia & Lymphoma|April 27, 2018
Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failureEthan B Ludmir, Sarah A Milgrom, Chelsea C Pinnix, et al.
Haematologica|June 30, 2017
Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutationRashmi Kanagal-Shamanna, Sanam Loghavi, Courtney D DiNardo, et al.
AIDS Research and Human Retroviruses|January 9, 2010
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entryJohn C Tilton, Heather Amrine-Madsen, John L Miamidian, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease ProgressionGuilin Tang, Shimin Hu, Sa A Wang, et al.
Cancer|June 16, 2010
Marginal zone lymphomas: factors that affect the final outcomeAli Mazloom, L Jeffrey Medeiros, Peter W McLaughlin, et al.
Annals of Hematology|May 11, 2013
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromesBin Fu, Chi Young Ok, Maitrayee Goswami, et al.
Pageof 110